InterventionsHumans

Association between Glucagon-like peptide-1 receptor agonists and risk of Arrhythmias: A Contemporary Real-World Analysis

AHA Scientific Sessions 2025 Abstract

The paper

Vikash Jaiswal, Muhammad Hanif, Aman Goyal,

Juveria Yasmin, Novonil Deb, Yusra Mashkoor, Kripa Rajak, Jishanth Mattumpuram,

Andrew M. Weinberg

JCCR Cardiology Research · Upstate Cardiovascular Group

AHA Scientific Sessions 2025 Abstract · 3 Nov 2025

Presented at AHA Scientific Sessions 2025 · Abstract 4368269

doi.org/10.1161/circ.152.suppl_3.4368269

GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism · 8 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Lancet · 4 Oct 2026